Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514 - SC Read more about Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514 - SC
Zai Lab Limited Announces Presentations at May Investor Conferences - SC Read more about Zai Lab Limited Announces Presentations at May Investor Conferences - SC
Zai Lab Limited to Announce Full Year 2017 Financial Results - SC Read more about Zai Lab Limited to Announce Full Year 2017 Financial Results - SC
Zai Lab Limited Appoints Billy Cho as Chief Financial Officer - SC Read more about Zai Lab Limited Appoints Billy Cho as Chief Financial Officer - SC
Zai Lab Limited to present at the Leerink Partners 7th Annual Global Healthcare Conference - SC Read more about Zai Lab Limited to present at the Leerink Partners 7th Annual Global Healthcare Conference - SC
Zai Lab Limited to present at the 36th Annual J.P. Morgan Healthcare Conference - SC Read more about Zai Lab Limited to present at the 36th Annual J.P. Morgan Healthcare Conference - SC
Zai Lab Limited Announces Dosing of First Patient in Phase 3 Registration Trial of ZL-2306 (niraparib) for Treatment of Ovarian Cancer - SC Read more about Zai Lab Limited Announces Dosing of First Patient in Phase 3 Registration Trial of ZL-2306 (niraparib) for Treatment of Ovarian Cancer - SC
Zai Lab Limited Announces Closing of U.S. Initial Public Offering of ADSs - SC Read more about Zai Lab Limited Announces Closing of U.S. Initial Public Offering of ADSs - SC
Zai Lab Limited Announces Upsizing of U.S. Initial Public Offering of ADSs - SC Read more about Zai Lab Limited Announces Upsizing of U.S. Initial Public Offering of ADSs - SC